North America organ-on-chip market is expected to grow by 33.7% annually in the forecast period and reach $178.6 million by 2030 owing to the rising use of organ-on-a-chip (OOC) in early detection of drug toxicity, increasing demand for personalized medicine, the emergence of OOC as an alternative to animal testing, the significant increase in research funding and venture capital investments.
Highlighted with 23 tables and 47 figures, this 99-page report “North America Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America organ-on-chip market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year because 2020 is not appropriate for research base due to the outbreak of COVID-19.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Five Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America organ-on-chip market in every aspect of the classification from perspectives of Offering, Organ Type, Material, Application, End User, and Country.
Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
- Chips
- Service
Based on Organ Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
- Liver-on-a-Chip
- Heart-on-a-Chip
- Lung-on-a-Chip
- Kidney-on-a-Chip
- Brain-on-a-Chip
- Skin-on-a-Chip
- Vessels-on-a-Chip
- Other Organ Types
Based on Material, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
- Polymers
- Glass
- Silicon
Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
- Drug Discovery
- Toxicology Research
- Other Applications
Based on End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Cosmetics Industry
- Other End Users
Geographically, the following national/local markets are fully investigated:
- U.S.
- Canada
- Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Organ Type, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
- AxoSim Inc.
- BiomimX SRL
- Cherry Biotech
- CN Bio Innovations, Ltd.
- Emulate Inc.
- Hurel Corporation
- InSphero AG
- Kirkstall, Ltd.
- MIMETAS BV
- Nortis Inc.
- Organovo, Inc.
- SynVivo, Inc.
- Tara Biosystems Inc.
- TissUse GmbH
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
What is the estimated value of the North American Organ-on-Chip Market?
What is the growth rate of the North American Organ-on-Chip Market?
What is the forecasted size of the North American Organ-on-Chip Market?
Who are the key companies in the North American Organ-on-Chip Market?
Report Attribute | Details |
---|---|
No. of Pages | 99 |
Published | July 2021 |
Forecast Period | 2020 - 2030 |
Estimated Market Value ( USD | $ 9.8 Million |
Forecasted Market Value ( USD | $ 178.6 Million |
Compound Annual Growth Rate | 33.7% |
Regions Covered | North America |
Table of Contents
1 Introduction1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis
3 Segmentation of North America Market by Offering
3.1 Market Overview by Offering
3.2 Chips
3.3 Service
4 Segmentation of North America Market by Organ Type
4.1 Market Overview by Organ Type
4.2 Liver-on-a-Chip
4.3 Heart-on-a-Chip
4.4 Lung-on-a-Chip
4.5 Kidney-on-a-Chip
4.6 Brain-on-a-Chip
4.7 Skin-on-a-Chip
4.8 Vessels-on-a-Chip
4.9 Other Organ Types
5 Segmentation of North America Market by Material
5.1 Market Overview by Material
5.2 Polymers
5.3 Glass
5.4 Silicon
6 Segmentation of North America Market by Application
6.1 Market Overview by Application
6.2 Drug Discovery
6.3 Toxicology Research
6.4 Other Applications
7 Segmentation of North America Market by End User
7.1 Market Overview by End User
7.2 Pharmaceutical and Biotechnology Companies
7.3 Academic and Research Institutes
7.4 Cosmetics Industry
7.5 Other End Users
8 North America Market 2019-2030 by Country
8.1 Overview of North America Market
8.2 U.S.
8.3 Canada
8.4 Mexico
9 Competitive Landscape
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
- AxoSim Inc.
- BiomimX SRL
- Cherry Biotech
- CN Bio Innovations, Ltd.
- Emulate Inc.
- Hurel Corporation
- InSphero AG
- Kirkstall, Ltd.
- MIMETAS BV
- Nortis Inc.
- Organovo, Inc.
- SynVivo, Inc.
- Tara Biosystems Inc.
- TissUse GmbH
- RELATED REPORTS
List of Tables
Table 1. Snapshot of North America Organ-on-Chip Market in Balanced Perspective, 2019-2030
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. World Health Spending by Region, $ bn, 2013-2020
Table 4. Main Product Trends and Market Opportunities in North America Organ-on-Chip Market
Table 5. North America Organ-on-Chip Market by Offering, 2019-2030, $ mn
Table 6. North America Organ-on-Chip Market by Organ Type, 2019-2030, $ mn
Table 7. North America Organ-on-Chip Market by Material, 2019-2030, $ mn
Table 8. North America Organ-on-Chip Market by Application, 2019-2030, $ mn
Table 9. North America Organ-on-Chip Market by End User, 2019-2030, $ mn
Table 10. North America Organ-on-Chip Market by Country, 2019-2030, $ mn
Table 11. U.S. Organ-on-Chip Market by Organ Type, 2019-2030, $ mn
Table 12. U.S. Organ-on-Chip Market by Application, 2019-2030, $ mn
Table 13. U.S. Organ-on-Chip Market by End User, 2019-2030, $ mn
Table 14. Canada Organ-on-Chip Market by Organ Type, 2019-2030, $ mn
Table 15. Canada Organ-on-Chip Market by Application, 2019-2030, $ mn
Table 16. Canada Organ-on-Chip Market by End User, 2019-2030, $ mn
Table 17. Mexico Organ-on-Chip Market by Organ Type, 2019-2030, $ mn
Table 18. Mexico Organ-on-Chip Market by Application, 2019-2030, $ mn
Table 19. Mexico Organ-on-Chip Market by End User, 2019-2030, $ mn
Table 20. AxoSim Inc.: Company Snapshot
Table 21. AxoSim Inc.: Business Segmentation
Table 22. AxoSim Inc.: Product Portfolio
Table 23. AxoSim Inc.: Revenue, 2017-2019, $ mnList of Figures
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 4. North America Organ-on-Chip Market, 2019-2030, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of North America Organ-on-Chip Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060
Figure 9. Primary Restraints and Impact Factors of North America Organ-on-Chip Market
Figure 10. Investment Opportunity Analysis
Figure 11. Porter’s Five Forces Analysis of North America Organ-on-Chip Market
Figure 12. Breakdown of North America Organ-on-Chip Market by Offering, 2019-2030, % of Revenue
Figure 13. North America Addressable Market Cap in 2021-2030 by Offering, Value ($ mn) and Share (%)
Figure 14. North America Organ-on-Chip Market: Chips, 2019-2030, $ mn
Figure 15. North America Organ-on-Chip Market: Service, 2019-2030, $ mn
Figure 16. Breakdown of North America Organ-on-Chip Market by Organ Type, 2019-2030, % of Sales Revenue
Figure 17. North America Addressable Market Cap in 2021-2030 by Organ Type, Value ($ mn) and Share (%)
Figure 18. North America Organ-on-Chip Market: Liver-on-a-Chip, 2019-2030, $ mn
Figure 19. North America Organ-on-Chip Market: Heart-on-a-Chip, 2019-2030, $ mn
Figure 20. North America Organ-on-Chip Market: Lung-on-a-Chip, 2019-2030, $ mn
Figure 21. North America Organ-on-Chip Market: Kidney-on-a-Chip, 2019-2030, $ mn
Figure 22. North America Organ-on-Chip Market: Brain-on-a-Chip, 2019-2030, $ mn
Figure 23. North America Organ-on-Chip Market: Skin-on-a-Chip, 2019-2030, $ mn
Figure 24. North America Organ-on-Chip Market: Vessels-on-a-Chip, 2019-2030, $ mn
Figure 25. North America Organ-on-Chip Market: Other Organ Types, 2019-2030, $ mn
Figure 26. Breakdown of North America Organ-on-Chip Market by Material, 2019-2030, % of Sales Revenue
Figure 27. North America Addressable Market Cap in 2021-2030 by Material, Value ($ mn) and Share (%)
Figure 28. North America Organ-on-Chip Market: Polymers, 2019-2030, $ mn
Figure 29. North America Organ-on-Chip Market: Glass, 2019-2030, $ mn
Figure 30. North America Organ-on-Chip Market: Silicon, 2019-2030, $ mn
Figure 31. Breakdown of North America Organ-on-Chip Market by Application, 2019-2030, % of Revenue
Figure 32. North America Addressable Market Cap in 2021-2030 by Application, Value ($ mn) and Share (%)
Figure 33. North America Organ-on-Chip Market: Drug Discovery, 2019-2030, $ mn
Figure 34. North America Organ-on-Chip Market: Toxicology Research, 2019-2030, $ mn
Figure 35. North America Organ-on-Chip Market: Other Applications, 2019-2030, $ mn
Figure 36. Breakdown of North America Organ-on-Chip Market by End User, 2019-2030, % of Revenue
Figure 37. North America Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%)
Figure 38. North America Organ-on-Chip Market: Pharmaceutical and Biotechnology Companies, 2019-2030, $ mn
Figure 39. North America Organ-on-Chip Market: Academic and Research Institutes, 2019-2030, $ mn
Figure 40. North America Organ-on-Chip Market: Cosmetics Industry, 2019-2030, $ mn
Figure 41. North America Organ-on-Chip Market: Other End Users, 2019-2030, $ mn
Figure 42. Breakdown of North America Organ-on-Chip Market by Country, 2019 and 2030F, % of Revenue
Figure 43. Contribution to North America 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 44. U.S. Organ-on-Chip Market, 2019-2030, $ mn
Figure 45. Canada Organ-on-Chip Market, 2019-2030, $ mn
Figure 46. Organ-on-Chip Market in Mexico, 2015-2030F, $ mn
Figure 47. Growth Stage of North America Organ-on-Chip Industry over the Forecast Period
Companies Mentioned
A selection of companies mentioned in this report includes:
- AxoSim Inc.
- BiomimX SRL
- Cherry Biotech
- CN Bio Innovations, Ltd.
- Emulate Inc.
- Hurel Corporation
- InSphero AG
- Kirkstall, Ltd.
- MIMETAS BV
- Nortis Inc.
- Organovo, Inc.
- SynVivo, Inc.
- Tara Biosystems Inc.
- TissUse GmbH
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Methodology
LOADING...